Clinical Trial Update: Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigates whether adding celecoxib to chemotherapy improves survival in patients with advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: University Hospital, Linkoeping | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: UNKNOWN